SCHEMBL5962069

SCHEMBL5962069

COC(OC)C(=O)C=CN(C)C.COC(OC)C(C)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.41
CYP1A2 P05177 4/20 0.41
CYP2C9 P11712 3/20 0.41
HPGD P15428 7/20 0.39
MEN1 O00255 5/20 0.39
KMT2A Q03164 5/20 0.39
LMNA P02545 3/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 6/20 0.37
L3MBTL1 Q9Y468 3/20 0.37
ALOX12 P18054 2/20 0.37
GLA P06280 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2D6 P10635 1/20 0.37
TDP1 Q9NUW8 3/20 0.35
POLB P06746 3/20 0.33
GAA P10253 2/20 0.33
RECQL P46063 3/20 0.33
KDM4E B2RXH2 2/20 0.33
DNMT1 P26358 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL950272 0.92 CYP2C19 (0.45) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL950271 0.92 CYP2C19 (0.45) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL13735642 0.83 CYP1A2 (0.43) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL13735641 0.83 CYP1A2 (0.43) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL25623926 0.75 CYP2C19 (0.41) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL16187811 0.74 CYP2C19 (0.51) CYP2C19CYP1A2CYP2C9HPGDMEN1
SCHEMBL317946 0.73
SCHEMBL4264708 0.68 KEAP1 (0.33)
SCHEMBL4264704 0.68 KEAP1 (0.33)
SCHEMBL16865867 0.68 KEAP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636227-A1 PYRIMIDINE DERIVATIVES POSSESSING CELL-CYCLE INHIBITORY ACTIVITY Astrazeneca AB (SE) 2006-03-22 EP disclosed
WO-2004101564-A1 PYRIMIDINE DERIVATIVES POSSESSING CELL-CYCLE INHIBITORY ACTIVITY ASTRAZENECA AB (SE) 2004-11-25 WO disclosed